$CEVA (CEVA Inc.)

$CEVA {{ '2016-08-16T17:52:14+0000' | timeago}} • Announcement

Signal processing IP licensor $CEVA said Novatek Microelectronics has licensed and deployed the CEVA-XM4 intelligent vision DSP for its next-generation vision-enabled System-on-Chips for use in advanced visual intelligence capabilities. They can be used in surveillance systems with face detection and authentication and drone anti-collision systems.

$MRK {{ '2017-07-26T13:49:00+0000' | timeago}} • Announcement

$MRK's BoD declared a quarterly dividend of $0.47 per share of its common stock for 4Q17. The dividend will be paid on Oct. 6, 2017 to shareholders of record at the close of business on Sept. 15, 2017.

$TXN {{ '2017-07-25T22:24:59+0000' | timeago}} • Announcement

Effective manufacturing strategy & shifting of analog production to 300mm wafer has helped $TXN increase its 2Q17 gross margin to 64.3% vs. 61.2% in 2Q16. Looking ahead, chipmaker expects 3Q17 revenues of $3.74 to 4.06 billion, and EPS between $1.04 and $1.18, which includes an estimated $20MM discrete tax benefit.

$TXN {{ '2017-07-25T22:07:31+0000' | timeago}} • Announcement

$TXN, which supplies chips to $AAPL (iPhone) for charging controller and power management reported strong segment results. Analog revenues increased 18% due to increased production of 300mm wafers, which is 40% cheaper vs 200mm wafers. Embedded Processing revenue grew 15% due to increased revenues from microcontrollers and processors product lines.

$TXN {{ '2017-07-25T21:47:25+0000' | timeago}} • Announcement

Dallas based chipmaker $TXN, which sells products to about 100,000 customers, reported impressive 2Q17 results, beating Street estimates. Revenue increased 13% backed by continued strong demand for its chips from automotive and industrial customers. The company reported Q2 EPS of $1.03 vs. Street consensus of $0.96.

$TXN {{ '2017-07-25T20:40:29+0000' | timeago}} • Infographic

$TXN Texas Instruments Earnings AlphaGraphics: Q2 2017 highlights

$MRK {{ '2017-07-25T17:08:10+0000' | timeago}} • Announcement

$MRK announced the presentation of results from the Drive-Ahead study, the second of two pivotal Phase 3 clinical trials evaluating the efficacy and safety of doravirine, the company's investigational, non-nucleoside reverse transcriptase inhibitor (NNRTI), for the treatment of HIV-1 infection.

$LW {{ '2017-07-25T13:48:53+0000' | timeago}} • Announcement

$LW appointed Andre Hawaux, COO of $DKS, and Hala Moddelmog, CEO of the Metro Atlanta Chamber, to its BoD, effective July 19, 2017. Executive Chairman Timothy McLevish has decided not to seek re-election to its BoD. The Board will appoint current lead independent director W.G. Jurgensen to the role of Non-Executive Chairman.

$MRK {{ '2017-07-25T11:50:57+0000' | timeago}} • Announcement

$MRK said that its anti-programmed cell death protein 1 (PD1) drug Keytruda (pembrolizumab) failed to meet the primary endpoint in the Phase III KEYNOTE-040 trial for previously treated recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). When compared with standard treatment, Keytruda failed to improve the overall survival rate.

$GOOGL {{ '2017-07-24T23:30:52+0000' | timeago}} • Webcast

$GOOGL is in the process of testing and developing Google Maps to enhance the customer experience. The company intends to roll out Store Sales Measurement in the coming months to enable advertisers to measure revenue, in addition to store visits. Going ahead, Google sees strong growth for YouTube across all platforms, including television.

$GOOGL {{ '2017-07-24T22:35:02+0000' | timeago}} • Webcast

For 3Q17, $GOOGL expects headcount additions to be seasonally high. Going ahead, significant contributions are expected from the growing non-ads revenue businesses, especially Google Play. Google continues to shift its focus to AI-driven computing, with efforts to make the technology available to people across the world.

$GOOGL {{ '2017-07-24T22:12:43+0000' | timeago}} • Webcast

$GOOGL said the 20% growth in search revenue in 2Q17 was driven mainly by mobile search and YouTube. The $2.8Bil capital expenditure reflected investments in production equipment facilities and development of data centers. The internet search leader raised its stock–based compensation by 40% annually to $1.9Bil in the second quarter.

$GOOGL {{ '2017-07-24T21:13:12+0000' | timeago}} • Announcement

$GOOGL said revenues of the Google segment grew 21% annually to $25.76Bil in 2Q17. Revenues of Other Bets division climbed 34% to $248MM. Revenues from US operations advanced 23%, and those from Europe, Middle East and Africa moved up 14%. APAC revenues grew 28%, while other Americas revenues dropped 8%.

$GOOGL {{ '2017-07-24T21:00:24+0000' | timeago}} • Announcement

Earnings of search service behemoth $GOOGL fell sharply in 2Q17, hurt by penalty imposed by the EU in an antitrust lawsuit. EPS dropped to $5.01 from $7 last year, despite a 21% rise in revenues. There was a 52% annual growth in aggregate paid clicks, while aggregate cost-per-click dropped 23%. Alphabet’s Other Bets division remained in loss.

$GOOG {{ '2017-07-24T20:58:25+0000' | timeago}} • Infographic

$GOOG $GOOGL Alphabet Earnings AlphaGraphics: Q2 2017 highlights

$CDNS {{ '2017-07-24T20:40:26+0000' | timeago}} • Announcement

For 3Q17, $CDNS expects total revenue in the range of $475-485MM. GAAP EPS is expected to be in the range of $0.24-0.26, while non-GAAP EPS is expected in the range of $0.33-0.35. For FY17, $CDNS expects total revenue in the range of $1.910-1.950Bil. For FY17, GAAP EPS is expected to be $0.98-1.04, while non-GAAP EPS is expected to be $1.36-1.42.

$CDNS {{ '2017-07-24T20:33:40+0000' | timeago}} • Announcement

Electronic design automation company $CDNS reported a 40% jump in 2Q17 earnings, driven by robust software and IP growth. Net earnings spiked to $69.12M or $0.25 per share from $49.34MM or $0.17 per share a year earlier. Revenue increased 5.73% $479MM. On an adjusted basis, the company earned $0.34 per diluted share.

$MRK {{ '2017-07-24T18:28:47+0000' | timeago}} • Announcement

$MRK today announced the US launch of RENFLEXIS, a biosimilar for Remicade, which was approved by FDA for all eligible indications. RENFLEXIS will have a wholesale acquisition cost of $753.39, which is a 35% discount compared to Remicade. Remicade was the fifth bestselling drug in the US in 2016 raking in $5.3Bil on an invoice price basis.

$MSI {{ '2017-07-24T18:07:53+0000' | timeago}} • Announcement

$MSI has filed fresh patent infringement complaints in the Regional Court of Mannheim in Germany against Hytera Communications Corporation Limited of Shenzhen, China and Hytera Mobilfunk GmbH of Bad Munder, Germany (collectively, “Hytera”). Similar complaints were filed against Hytera in the Regional Court of Düsseldorf on April 18, 2017.

$AMAT {{ '2017-07-24T15:52:06+0000' | timeago}} • Announcement

$AMAT, a provider of materials engineering solutions, has appointed Dan Durn as SVP, effective August 7, 2017. Durn, a semiconductor industry veteran, will assume the role of CFO also, effective August 24. Most recently, Durn served NXP Semiconductors as CFO. Earlier, he held leadership positions in Freescale Semiconductor and Globalfoundries.

$CSCO {{ '2017-07-24T13:25:09+0000' | timeago}} • Announcement

$CSCO is partnering with the TIM Group to renew TIM's Optical Packet Metro (OPM) network. TIM's new OPM network will integrate $CSCO’s ASR 9000 technology, which will help TIM to effectively digitize its fixed and mobile line services. The investment is part of TIM's 3-year plan for 2017-2019, and involves an investment of about EUR5Bil.

Recent Transcripts

TXN (Texas Instruments Inc.)
Tuesday, July 25 2017 - 9:00pm
RMBS (Rambus Inc.)
Monday, July 24 2017 - 9:00pm
CDNS (Cadence Design Systems Inc.)
Monday, July 24 2017 - 9:00pm
GOOGL (Alphabet Inc.)
Monday, July 24 2017 - 9:00pm
MXIM (Maxim Integrated Products, Inc.)
Thursday, July 20 2017 - 9:00pm
IBM (International Business Machines Corporation)
Tuesday, July 18 2017 - 9:00pm
TSM (Taiwan Semiconductor Manufacturing Company Limited)
Thursday, July 13 2017 - 6:00am
YGE (Yingli Green Energy Holding Co. Ltd.)
Thursday, June 15 2017 - 12:00pm
ADI (Analog Devices Inc)
Wednesday, May 31 2017 - 2:00pm
INTU (Intuit Inc.)
Tuesday, May 23 2017 - 8:30pm
AMAT (Applied Materials Inc)
Thursday, May 18 2017 - 8:30pm
SNPS (Synopsys Inc.)
Wednesday, May 17 2017 - 9:00pm
CSCO (Cisco Systems, Inc.)
Wednesday, May 17 2017 - 8:30pm
DKS (Dick's Sporting Goods Inc.)
Tuesday, May 16 2017 - 2:00pm
EMAN (eMagin Corp.)
Thursday, May 11 2017 - 1:00pm
ASYS (Amtech Systems Inc)
Wednesday, May 10 2017 - 9:00pm
NVDA (NVIDIA Corporation)
Tuesday, May 9 2017 - 9:00pm
MSI (Motorola Solutions, Inc.)
Thursday, May 4 2017 - 9:00pm
MDRX (Allscripts Healthcare Solutions, Inc.)
Thursday, May 4 2017 - 8:30pm
ACIW (ACI Worldwide, Inc.)
Thursday, May 4 2017 - 12:30pm

AlphaGraphics you may like